Parkman Healthcare Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-93,431
| Closed | -$3.53M | – | 98 |
|
|
2025
Q1 | $3.53M | Sell |
93,431
-22,707
| -20% | -$857K | 0.42% | 61 |
|
|
2024
Q4 | $9.51M | Sell |
116,138
-14,111
| -11% | -$1.16M | 1.27% | 31 |
|
|
2024
Q3 | $14.9M | Sell |
130,249
-19,942
| -13% | -$2.28M | 1.9% | 18 |
|
|
2024
Q2 | $11.3M | Buy |
150,191
+235
| +0.2% | +$17.7K | 1.52% | 22 |
|
|
2024
Q1 | $10.2M | Sell |
149,956
-117,638
| -44% | -$8.04M | 1.26% | 31 |
|
|
2023
Q4 | $16.8M | Buy |
267,594
+29,462
| +12% | +$1.85M | 2.37% | 13 |
|
|
2023
Q3 | $12.1M | Buy |
238,132
+9,627
| +4% | +$491K | 2.22% | 9 |
|
|
2023
Q2 | $11.4M | Buy |
228,505
+42,408
| +23% | +$2.12M | 1.98% | 14 |
|
|
2023
Q1 | $6.97M | Buy |
186,097
+28,049
| +18% | +$1.05M | 1.52% | 28 |
|
|
2022
Q4 | $7.58M | Buy |
+158,048
| New | +$7.58M | 2.02% | 13 |
|